---
figid: PMC4061164__ott-7-1015Fig1
figlink: /pmc/articles/PMC4061164/figure/f1-ott-7-1015/
number: F1
caption: 'Cisplatin-induced inflammation is mediated through multiple effectors including
  activation of NFkB, TNF-α, and PARP. NFkB is a focal point for downstream cell survival
  and proliferation signaling that involves IL-6 and IL-8 upregulation. Cisplatin
  also induces the MAPK/ERK pathway and EMT acquisition. The ERK signaling cascade
  is suggested as an upstream signal for TNF-α activation.Abbreviations: ADP-ribose,
  poly; COX-2, cyclooxygenase; EMT, epithelial–mesenchymal transition; ERK, mitogen-activated
  protein kinase; HGF, hepatocyte growth factor; HIF-α, hypoxia-inducible factor;
  ICAM-1, intercellular adhesion molecule; IL, interleukin; MAPK, mitogen-activated
  protein kinase; MMP, matrix metalloproteinase; NFκB, nuclear factor kappa B; PARP,
  polymerase; STAT-3, signal transducer and activator of transcription; TNF-α, tumor
  necrosis factor alpha; VCAM-1, vascular cell adhesion molecule; VEGF, vascular endothelial
  growth factor.'
pmcid: PMC4061164
papertitle: Chemotherapy-enhanced inflammation may lead to the failure of therapy
  and metastasis.
reftext: Dinesh Vyas, et al. Onco Targets Ther. 2014;7:1015-1023.
pmc_ranked_result_index: '123388'
pathway_score: 0.7279006
filename: ott-7-1015Fig1.jpg
figtitle: Cisplatin-induced inflammation is mediated through multiple effectors including
  activation of NFkB, TNFA, and PARP
year: '2014'
organisms:
- Mus musculus
- Rattus norvegicus
- Candida dubliniensis
- Homo sapiens
ndex: 676bbe70-df30-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4061164__ott-7-1015Fig1.html
  '@type': Dataset
  description: 'Cisplatin-induced inflammation is mediated through multiple effectors
    including activation of NFkB, TNF-α, and PARP. NFkB is a focal point for downstream
    cell survival and proliferation signaling that involves IL-6 and IL-8 upregulation.
    Cisplatin also induces the MAPK/ERK pathway and EMT acquisition. The ERK signaling
    cascade is suggested as an upstream signal for TNF-α activation.Abbreviations:
    ADP-ribose, poly; COX-2, cyclooxygenase; EMT, epithelial–mesenchymal transition;
    ERK, mitogen-activated protein kinase; HGF, hepatocyte growth factor; HIF-α, hypoxia-inducible
    factor; ICAM-1, intercellular adhesion molecule; IL, interleukin; MAPK, mitogen-activated
    protein kinase; MMP, matrix metalloproteinase; NFκB, nuclear factor kappa B; PARP,
    polymerase; STAT-3, signal transducer and activator of transcription; TNF-α, tumor
    necrosis factor alpha; VCAM-1, vascular cell adhesion molecule; VEGF, vascular
    endothelial growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HGF
  - IL1B
  - IL1A
  - MAPK1
  - HIF3A
  - ICAM1
  - NFKB1
  - MAPK3
  - VEGFA
  - TNKS2
  - NFKB2
  - HIF1A
  - PARP14
  - EPAS1
  - PARP9
  - IL18
  - REL
  - PARP16
  - CDH1
  - PGF
  - TIPARP
  - PARP12
  - TNF
  - VEGFB
  - VEGFC
  - STAT3
  - IL6
  - PARP8
  - VCAM1
  - PARP11
  - MMP2
  - VEGFD
  - PARP3
  - TNKS
  - RELA
  - MMP9
  - RELB
  - PARP6
  - CXCL8
  - PARP2
  - PARP15
  - PARP1
  - PARP10
  - PARP4
  - Cisplatin
genes:
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: ICAM-1
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: NfkB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: NfkB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: NfkB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: STAT-3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: VCAM-1
  symbol: VCAM1
  source: hgnc_symbol
  hgnc_symbol: VCAM1
  entrez: '7412'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: MMP-2
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: NfkB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: MMP-9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: NfkB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: IL-8,
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
chemicals:
- word: Cisplatin
  source: MESH
  identifier: D002945
diseases: []
figid_alias: PMC4061164__F1
redirect_from: /figures/PMC4061164__F1
figtype: Figure
---
